IBANDRONATE Spirig HC 150 mg compr mensuels

7680631190030 CH-63119 M05BA06 07.99.0.

Reimbursement limitations:

BONVIVA

Pour le traitement de l'ostéoporose documentée.

IBANDRONATE Spirig HC 150 mg compr mensuels
IBANDRONATE Spirig HC 150 mg compr mensuels
IBANDRONATE Spirig HC 150 mg compr mensuels
1 / 3
google

Details

Product number
6311901
CPT
-
Packaging group
1
Unit
Tablette(n)
Composition
acidum ibandronicum 150 mg ut natrii ibandronas monohydricus, cellulosum microcristallinum, povidonum, crospovidonum, silica colloidalis anhydrica, acidum stearicum, Überzug: E 171, hypromellosum, macrogolum 400, polysorbatum 80, pro compresso obducto corresp. natrium 10.8 mg.

Articles (1)

Ibandronat Spirig HC 150 mg Monatstabletten, Filmtabletten
Filmtabletten
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/09/2022
Patient information leaflet
Français
13/09/2022
Patient information leaflet
Italien
13/09/2022
Professional SmPC
Allemand
13/09/2022
Professional SmPC
Français
13/09/2022

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
10.8 MG Substance HBESI

Reimbursement information

Public price
CHF 32.30
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/06/2013

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
63119
Drug name
Ibandronat Spirig HC Monatstabletten, Filmtabletten
Galenic form
FILM
ATC Code
M05BA06
Authorization status
Z
Authorization category
Category C
Dispensation category
B
First authorization
26/03/2013
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Packaging details

Description (FR)
IBANDRONATE Spirig HC 150 mg compr mensuels
Description (DE)
IBANDRONAT Spirig HC 150 mg Monatstabl
Market launch
26/03/2013
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
CHF 210.75
View original

Other packaging sizes

IBANDRONATE Spirig HC 150 mg compr mensuels 3 pce
3 TABL
View